Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations
- 31 October 2009
- journal article
- case report
- Published by Elsevier BV in Surgical Neurology
- Vol. 72 (4), 423-428
- https://doi.org/10.1016/j.surneu.2008.09.023
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Anti‐O6‐Methylguanine‐Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker*Brain Pathology, 2008
- Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomideCancer, 2008
- Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrenceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Clinical Applications of PET in Brain TumorsJournal of Nuclear Medicine, 2007
- Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized TrialJournal of Clinical Oncology, 2006
- Positron Emission Tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus Magnetic Resonance Imaging in the Diagnosis of Recurrent GliomasNeurosurgery, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-l-tyrosine and magnetic resonance spectroscopyJournal of Neurosurgery, 2005
- Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.American Journal of Roentgenology, 1994
- Demonstration of Cerebral Radiation Injury with Metabolic Positron Emission Tomography ImagesPediatric Neurosurgery, 1991